Literature DB >> 8796627

Hepatic transport of gadobenate dimeglumine in TR-rats.

C de Haën1, V Lorusso, P Tirone.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8796627     DOI: 10.1016/s1076-6332(96)80614-3

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


× No keyword cloud information.
  10 in total

Review 1.  Hepatobiliary MR imaging with gadolinium-based contrast agents.

Authors:  Alex Frydrychowicz; Meghan G Lubner; Jeffrey J Brown; Elmar M Merkle; Scott K Nagle; Neil M Rofsky; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2012-03       Impact factor: 4.813

2.  Dynamic Contrast-Enhanced MRI of OATP Dysfunction in Diabetes.

Authors:  Dorela D Shuboni-Mulligan; Maciej Parys; Barbara Blanco-Fernandez; Christiane L Mallett; Regina Schnegelberger; Marilia Takada; Shatadru Chakravarty; Bruno Hagenbuch; Erik M Shapiro
Journal:  Diabetes       Date:  2018-11-28       Impact factor: 9.461

Review 3.  Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.

Authors:  Peter Reimer; Günter Schneider; Wolfgang Schima
Journal:  Eur Radiol       Date:  2004-02-25       Impact factor: 5.315

4.  Gd-EOB-DTPA-Enhanced MRI for Detection of Liver Metastases from Colorectal Cancer: A Surgeon's Perspective!

Authors:  Kelly J Lafaro; Panayota Roumanis; Aram N Demirjian; Chandana Lall; David K Imagawa
Journal:  Int J Hepatol       Date:  2013-04-09

Review 5.  Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media.

Authors:  Carlo Bartolozzi; Laura Crocetti; Riccardo Lencioni; Dania Cioni; Clotilde Della Pina; Daniela Campani
Journal:  Eur Radiol       Date:  2007-02-16       Impact factor: 7.034

6.  Compensatory biliary and urinary excretion of gadobenate ion after administration of gadobenate dimeglumine (MultiHance(®)) in cases of impaired hepatic or renal function: a mechanism that may aid in the prevention of nephrogenic systemic fibrosis?

Authors:  M A Kirchin; V Lorusso; G Pirovano
Journal:  Br J Radiol       Date:  2015-02-04       Impact factor: 3.039

7.  Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats.

Authors:  Thomas Frenzel; Chirag Apte; Gregor Jost; Laura Schöckel; Jessica Lohrke; Hubertus Pietsch
Journal:  Invest Radiol       Date:  2017-07       Impact factor: 6.016

8.  Diagnostic value of gadobenate dimeglumine-enhanced hepatocyte-phase magnetic resonance imaging in evaluating hepatic fibrosis and hepatitis.

Authors:  Xiu-Mei Li; Zhu Chen; En-Hua Xiao; Quan-Liang Shang; Cong Ma
Journal:  World J Gastroenterol       Date:  2017-05-07       Impact factor: 5.742

9.  Isolated Perfused Rat Livers to Quantify the Pharmacokinetics and Concentrations of Gd-BOPTA.

Authors:  Catherine M Pastor
Journal:  Contrast Media Mol Imaging       Date:  2018-07-11       Impact factor: 3.161

Review 10.  Theranostics and contrast agents for magnetic resonance imaging.

Authors:  Yohan Jeong; Hee Sook Hwang; Kun Na
Journal:  Biomater Res       Date:  2018-07-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.